Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Cyclerion Therapeutics (CYCN) Shares Outstanding (2019 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Shares Outstanding for 7 consecutive years, with $3.8 million as the latest value for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 986.57% year-over-year to $3.8 million; the TTM value through Sep 2025 reached $3.8 million, up 986.57%, while the annual FY2024 figure was $2.7 million, 672.03% up from the prior year.
  • Shares Outstanding hit $3.8 million in Q3 2025 for Cyclerion Therapeutics, up from $3.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $43.3 million in Q3 2021 and bottomed at $225000.0 in Q1 2023.
  • Average Shares Outstanding over 5 years is $8.0 million, with a median of $2.4 million recorded in 2023.
  • Year-over-year, Shares Outstanding plummeted 94.98% in 2022 and then skyrocketed 1010.93% in 2024.
  • Cyclerion Therapeutics' Shares Outstanding stood at $2.2 million in 2021, then grew by 0.25% to $2.2 million in 2022, then crashed by 83.87% to $351037.0 in 2023, then surged by 672.03% to $2.7 million in 2024, then soared by 40.74% to $3.8 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $3.8 million, $3.1 million, and $3.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.